Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory cells in transplantation.

Kathryn J Wood1, Hidetake Ushigome, Mahzuz Karim

  • 1Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.

Novartis Foundation Symposium
|November 12, 2003
PubMed
Summary

Regulatory T cells, specifically CD4+CD25+ T cells, are key to preventing organ transplant rejection. These cells, dependent on IL-10 and CTLA4, offer a path to permanent graft survival without long-term immunosuppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing incidence and serotype trends in ANCA-associated vasculitis: a 30-year population-based study in Norfolk, UK.

Rheumatology (Oxford, England)·2026
Same author

Kidney transplantation in obese Black patients: Strategies to improve access and outcomes.

World journal of nephrology·2026
Same author

Occlusion of TCR binding to HLA-A*11:01 by a non-pathogenic human alloantibody.

Cellular and molecular life sciences : CMLS·2025
Same author

Antigen-antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function.

Frontiers in immunology·2025
Same author

Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants.

Med (New York, N.Y.)·2024
Same author

Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.

Transplantation·2024

Area of Science:

  • Immunology
  • Transplantation Biology

Background:

  • Regulatory T cells (Tregs) are crucial for immune tolerance to foreign antigens.
  • Alloantigen-specific Tregs, particularly CD4+CD25+ T cells, show promise in transplantation settings.
  • Inducing and manipulating Tregs can prevent graft rejection.

Purpose of the Study:

  • To investigate the role of CD4+CD25+ regulatory T cells in alloantigen tolerance.
  • To explore the mechanisms underlying Treg-mediated suppression of transplant rejection.
  • To assess the potential of alloantigen-specific Tregs for long-term graft survival.

Main Methods:

  • Enrichment and characterization of CD4+CD25+ T cells with donor alloantigen specificity.
  • In vivo studies to assess Treg-mediated control of CD4+ and CD8+ T cell responses.

Related Experiment Videos

  • Analysis of the dependence of Tregs on interleukin-10 (IL-10) and CTLA4 for function.

    • Main Results:

    • CD4+CD25+ Tregs effectively control aggressive T cell responses, preventing graft rejection.
    • These Tregs mediate linked unresponsiveness and are dependent on IL-10 and CTLA4 in vivo.
    • Induced Tregs share properties with naturally occurring Tregs.

    Conclusions:

    • Alloantigen-specific Tregs can actively suppress immune responses to donor antigens, protecting grafts.
    • Generating Tregs with defined specificity offers dynamic control over rejection.
    • This approach presents a potential strategy for permanent graft survival without non-specific immunosuppression.